Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Change in Receivables (2016 - 2025)

Rockwell Medical's Change in Receivables history spans 16 years, with the latest figure at $61000.0 for Q4 2025.

  • For Q4 2025, Change in Receivables rose 110.41% year-over-year to $61000.0; the TTM value through Dec 2025 reached $98000.0, up 103.75%, while the annual FY2025 figure was $98000.0, 103.75% up from the prior year.
  • Change in Receivables reached $61000.0 in Q4 2025 per RMTI's latest filing, down from $244000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $4.0 million in Q3 2023 to a low of -$2.0 million in Q3 2024.
  • Average Change in Receivables over 5 years is $210900.0, with a median of -$31000.0 recorded in 2021.
  • Peak YoY movement for Change in Receivables: tumbled 800.81% in 2022, then surged 646.33% in 2023.
  • A 5-year view of Change in Receivables shows it stood at -$123000.0 in 2021, then crashed by 800.81% to -$1.1 million in 2022, then surged by 238.99% to $1.5 million in 2023, then crashed by 138.05% to -$586000.0 in 2024, then soared by 110.41% to $61000.0 in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Change in Receivables are $61000.0 (Q4 2025), $244000.0 (Q3 2025), and -$1.6 million (Q2 2025).